Company: Eli Lilly
Job title: Research Advisor & Head of Molecular Pathology, Neuroscience
Suchira Bose has a background in protein folding/ mis-folding and molecular chaperones. Following her Ph.D she obtained a long-term EMBO fellowship to understand the molecular mechanisms of Hsp90 function at the University of Regensburg, Germany. She then completed her postdoctoral training at the University of Bristol, where she studied the role of post-translational modification on proteasome function. She joined Lilly Neuroscience in 2001 and has over 19 years of experience in neurodegeneration research and drug discovery with expertise in pre-clinical models and target validation. She is currently a Research Advisor & Group Leader heading an in vitro and neuropathology team in the Neuroscience Team, focusing on protein mis-folding and neurodegenerative diseases including tau and synuclein pathology.
Reviewing Tau as a Therapeutic Strategy for Neurodegenerative Diseases 12:00 pm
• Tau normal function and dysfunction in Alzheimer’s disease and other neurodegenerative diseases • Tau aggregation: biochemical and structural insights • New insights in tau dysfunction: developing models to study ‘prion-like’ propagationRead more
day: Day One